How is EURO-FARM positioned among the leading pharmaceutical companies in Macedonia?

The Macedonian pharmaceutical sector is one of the most stable segments of the domestic economy. It encompasses companies with different business models – from drug manufacturers, through wholesalers and importers, to pharmacy chains – but what they all have in common is their main goal, which is the provision and delivery of the highest quality medicines and medical products.

Although these companies are part of the same healthcare ecosystem, their activities differ significantly, which is why financial results should be analyzed in the context of their core business.

The largest pharmaceutical manufacturer in North Macedonia is Alkaloid AD Skopje , a company that, in addition to the domestic market, is strongly oriented towards export and has its own production facilities and development centers.

On the other hand, Replek AD Skopje is a recognizable manufacturer of pharmaceutical products and medical preparations, which is also strongly export-oriented and accumulates foreign capital, while EURO-FARM, Zegin, Makedonijalek and other wholesalers play a key role in the import, distribution and supply of pharmacies and healthcare institutions with medicines and medical products.

Although most of the attention in the Macedonian pharmaceutical industry has traditionally been attracted by manufacturers such as Alkaloid and Replek, the role of wholesalers is equally important for the functioning of the healthcare system.

Drug production could not function efficiently without well-organized distribution, which ensures that products reach pharmacies, hospitals, and patients on time.

In that segment, EURO-FARM has been one of the most significant participants in the domestic market for years. The integrated model, which unites wholesale and retail through its own pharmacy network, allows it to better plan purchases, more efficiently manage inventory, and respond faster to market needs.

Proof of the company's quality performance are the positive financial results and its constant listing on the rankings of the largest and most successful companies within the 200 LARGEST AND MOST SUCCESSFUL project.

How does EURO-FARM rank on the ranking list of the largest companies?

According to financial indicators, in 2024, EURO-FARM ranked 88th on the ranking list of the largest Macedonian companies .

The company achieved revenues of over 3.66 billion denars, with a growth of 7.47 percent compared to the previous year , and at the same time increased its profit before tax by 7.15 percent , indicating stable and continuous development.

The almost identical growth rate of revenue and profit compared to the previous year shows that the company managed to increase its operating volume in that fiscal year without significantly disrupting profitability.

This, in itself, is an important indicator of good cost management and stable business policy in a sector where efficient logistics, inventory control, and timely delivery are of crucial importance.

What makes EURO-FARM different from all other companies in the pharmaceutical sector in North Macedonia?

What particularly sets the company apart from the competition is its integrated business model.

In addition to being one of the largest wholesale drugstores in the country, EURO-FARM also has a developed retail network of more than 120 pharmacies throughout North Macedonia, as well as exclusive dealerships for numerous international pharmaceutical, medical and cosmetic brands that can only be found in their pharmacies, and are recognizable for their quality .

It is a business model that allows for better control of the supply chain, faster product availability, and greater recognition among consumers , thus creating a larger base of loyal customers.

Pharmaceutical distribution requires speed, reliability and trust

Unlike many other commercial activities, pharmaceutical distribution operates under strict regulations and high quality standards.

Companies are under constant pressure to ensure continuous availability of medicines, appropriate transportation and storage conditions, as well as a system that allows for product tracking throughout the entire supply chain.

In addition to regulatory requirements, the sector faces additional challenges, such as occasional disruptions in global supply chains, rising transportation costs, inflationary pressures, and the need for continued investment in modern logistics systems and digitalization.

In such a business environment, the stable growth of EURO-FARM shows that the company successfully manages these risks and ensures security of supply to its partners.

The growth of the pharmaceutical market creates new opportunities

The Macedonian pharmaceutical market has seen continuous development in recent years – largely due to the aging population, increased health awareness, the introduction of new therapies, and the increasing demand for medical products.

At the same time, healthcare institutions and pharmacies expect faster delivery, greater product availability, and a higher level of service.

This further increases the importance of companies that have a well-organized distribution network and modern logistics capacities, such as the example of EURO-FARM.

In such conditions, success depends not only on sales volume, but also on the company's ability to meet market needs in a timely manner with the highest quality products and to ensure a reliable supply chain and product availability.

This has proven to be a solid operating model, which helps EURO-FARM maintain its high position among the competition in the pharmaceutical sector.

Human capital remains a key resource

Although digitalization has imposed itself as necessary in the pharmaceutical industry, through the creation of online pharmacies and delivery, tracking of medications and supplies, as well as their fast and timely delivery - the human factor remains crucial.

Professional staff, good organization, and efficient coordination between procurement, logistics, and sales are key to the successful functioning of the company.

In that regard, the relatively small number of employees with whom EURO-FARM operates is proof of the quality and dedicated work, that is, the company's orientation towards productivity and positive financial results.

With an average of 99 employees, EURO-FARM manages to generate revenues of over 3.6 billion denars, which indicates high productivity and efficient use of available resources.

Good prospects for further development

The financial results for 2024 show that EURO-FARM successfully maintains its position among the leading companies in the pharmaceutical sales sector.

The continuous growth of revenues and profits, stable operations and presence among the largest companies in the country confirm that the company has a sound business model and the capacity for further development.

In such conditions, EURO-FARM DOOEL Bitola has been building a recognizable position as one of the most significant companies in the pharmaceutical sales sector in Macedonia for years. The continuous growth of revenues and positive financial results show that the company is successfully adapting to market changes and following the increasing needs of the healthcare sector.

At a time when the healthcare sector is becoming increasingly dependent on secure and efficient supply chains, the role of companies like EURO-FARM will be even more important.

Continued investments in logistics, opening new pharmacies, digitalization, and improving services will remain key factors for maintaining competitiveness and further growth.

In a situation where the pharmaceutical sector is becoming increasingly competitive, and healthcare institutions and pharmacies expect fast delivery, reliability and continuous availability of products, companies that have well-organized logistics, a developed distribution network and stable partnerships have the greatest opportunities for further growth.

The financial results for 2024 show that EURO-FARM successfully maintains exactly such a position on the domestic market . In addition, the financial results in the last 20 years since EURO-FARM became part of the 200 LARGEST AND MOST SUCCESSFUL indicate a company that remains oriented towards its primary goal – to work primarily for the health of its customers, and thus to maintain its high positioning among companies focused on the sale of medicines and medical preparations in the pharmaceutical sector in Macedonia.